The DOI matches its Crossref record; 112 of the 112 references it cites were found in a registry or an index.
Brain Cholesterol: Long Secret Life Behind a Barrier
Abstract
Although an immense knowledge has accumulated concerning regulation of cholesterol homeostasis in the body, this does not include the brain, where details are just emerging. Approximately 25% of the total amount of the cholesterol present in humans is localized to this organ, most of it present in myelin. Almost all brain cholesterol is a product of local synthesis, with the blood-brain barrier efficiently protecting it from exchange with lipoprotein cholesterol in the circulation. Thus, there is a highly efficient apolipoprotein-dependent recycling of cholesterol in the brain, with minimal losses to the circulation. Under steady-state conditions, most of the de novo synthesis of cholesterol in the brain appears to be balanced by excretion of the cytochrome P-450-generated oxysterol 24S-hydroxycholesterol. This oxysterol is capable of escaping the recycling mechanism and traversing the blood-brain barrier. Cholesterol levels and cholesterol turnover are affected in neurodegenerating disorders, and the capacity for cholesterol transport and recycling in the brain seems to be of importance for the development of such diseases. The possibility has been discussed that administration of inhibitors of cholesterol synthesis may reduce the prevalence of Alzheimer disease. No firm conclusions can, however, be drawn from the studies presented thus far. In the present review, the most recent advances in our understanding of cholesterol turnover in the brain is discussed.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The adult brain relies on endogenous synthesis for its cholesterol needs because the blood-brain barrier is virtually impermeable to circulating lipoproteins and cholesterol molecules do not cross the blood-brain barrier.
“The adult brain vastly relies on endogenous synthesis for its cholesterol needs since the BBB is virtually impermeable to circulating lipoproteins (52) and since, unlike oxysterols, cholesterol molecules do not cross the BBB (53).”
From PCSK9 and the nervous system: a no-brainer? (2023) · cites this paper as [52]
Disruption of cholesterol homeostasis perturbs cell-autonomous and non-cell-autonomous functions, including inhibition of crucial signaling pathways and cellular crosstalk.
“Disruption of cholesterol homeostasis has also been shown to perturb cell-autonomous and non-cell-autonomous functions, including inhibition of crucial signaling pathways and cellular crosstalk (Bjorkhem and Meaney, 2004; Martin et al., 2014).”
From Sterol dysregulation in Smith–Lemli–Opitz syndrome causes astrocyte immune reactivity through microglia crosstalk (2022) · cites this paper as Bjorkhem and Meaney, 2004
Cholesterol is essential for neurons, because a lack of cholesterol leads to synapse degeneration, impaired synaptic vesicle exocytosis and neurotransmission, and overall decreased neuronal activity.
“Cholesterol is essential for neurons, because a lack of cholesterol leads to synapse degeneration, impaired synaptic vesicle exocytosis and neurotransmission, and overall decreased neuronal activity.[42][43][44]”
From Canonical Wnt pathway and the LDL receptor superfamily in neuronal cholesterol homeostasis and function (2024) · cites this paper as [42]
The most abundant brain lipids are cholesterol, ceramides, glucosyl ceramides, phosphatidylcholine, sphingomyelin, and sulfatides.
“Out of all the brain lipids, the most abundant are cholesterol, ceramides, glucosyl ceramides, phosphatidylcholine, sphingomyelin, and sulfatides [61, 62].”
From Recent Advancements in Pathogenesis, Diagnostics and Treatment of Alzheimer’s Disease (2020) · cites this paper as [61]
Citations
Cites
Corder, E. H., Saunders, A. M., Strittmatter, W. J., Schmechel, D. E., Gaskell, P. C., Small, G. W., Roses, A. D., Haines, J. L., & Pericak-Vance, M. A. (1993) · Science · doi:10.1126/science.8346443 · Cited by 9,429
Association of apolipoprotein E allele ϵ4 with late‐onset familial and sporadic Alzheimer's disease
Saunders, A. M., Strittmatter, W. J., Schmechel, D., St. George-Hyslop, P. H., Pericak-Vance, M. A., Joo, S. H., Rosi, B. L., Gusella, J. F., Crapper-MacLachlan, D. R., Alberts, M. J., et al. (1993) · Neurology · doi:10.1212/wnl.43.8.1467 · Cited by 3,786
Shepherd, J., Blauw, G. J., Murphy, M. B., Bollen, E. L., Buckley, B. M., Cobbe, S. M., Ford, I., Gaw, A., Hyland, M., Jukema, J. W., et al. (2002) · The Lancet · doi:10.1016/s0140-6736(02)11600-x · Cited by 3,378
FINE STRUCTURAL LOCALIZATION OF A BLOOD-BRAIN BARRIER TO EXOGENOUS PEROXIDASE
Reese, T. S., & Karnovsky, M. J. (1967) · The Journal of Cell Biology · doi:10.1083/jcb.34.1.207 · Cited by 2,629
Statins and the risk of dementia
Jick, H., Zornberg, G. L., Jick, S. S., Seshadri, S. S., & Drachman, D. (2000) · The Lancet · doi:10.1016/s0140-6736(00)03155-x · Cited by 1,764
CNS synaptogenesis promoted by glia-derived cholesterol
Mauch, D. H., Nägler, K., Schumacher, S., Göritz, C., Müller, E.-C., Otto, A., & Pfrieger, F. W. (2001) · Science · doi:10.1126/science.294.5545.1354 · Cited by 1,711
An oxysterol signalling pathway mediated by the nuclear receptor LXRα
Janowski, B. A., Willy, P. J., Devi, T. R., Falck, J. R., & Mangelsdorf, D. J. (1996) · Nature · doi:10.1038/383728a0 · Cited by 1,591
Wolozin, B. L. (2000) · Archives of Neurology · doi:10.1001/archneur.57.10.1439 · Cited by 1,408
Trommsdorff, M., Gotthardt, M., Hiesberger, T., Shelton, J., Stockinger, W., Nimpf, J., Hammer, R. E., Richardson, J. A., & Herz, J. (1999) · Cell · doi:10.1016/s0092-8674(00)80782-5 · Cited by 1,261
Activation of the Nuclear Receptor LXR by Oxysterols Defines a New Hormone Response Pathway
Lehmann, J. M., Kliewer, S. A., Moore, L. B., Smith-Oliver, T. A., Oliver, B. B., Su, J.-L., Sundseth, S. S., Winegar, D. A., Blanchard, D. E., Spencer, T. A., et al. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.6.3137 · Cited by 1,233
Cholesterol metabolism in the brain
Dietschy, J. M., & Turley, S. D. (2001) · Current Opinion in Lipidology · doi:10.1097/00041433-200104000-00003 · Cited by 906
Boyles, J. K., Pitas, R. E., Wilson, E., Mahley, R. W., & Taylor, J. M. (1985) · Journal of Clinical Investigation · doi:10.1172/jci112130 · Cited by 829
Apolipoprotein E: a pathological chaperone protein in patients with cerebral and systemic amyloid
Wisniewski, T., & Frangione, B. (1992) · Neuroscience Letters · doi:10.1016/0304-3940(92)90444-c · Cited by 802
The Role of Orphan Nuclear Receptors in the Regulation of Cholesterol Homeostasis
Repa, J. J., & Mangelsdorf, D. J. (2000) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.16.1.459 · Cited by 762
Pitas, R. E., Boyles, J. K., Lee, S. H., Hui, D., & Weisgraber, K. H. (1987) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)47945-8 · Cited by 714
Astrocytes synthesize apolipoprotein E and metabolize apolipoprotein E-containing lipoproteins
Pitas, R. E., Boyles, J. K., Lee, S. H., Foss, D., & Mahley, R. W. (1987) · Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism · doi:10.1016/0005-2760(87)90295-5 · Cited by 693
Association of apolipoprotein E polymorphism with outcome after head injury
Teasdale, G. M., Nicoll, J. A. R., Murray, G. D., & Fiddes, M. (1997) · The Lancet · doi:10.1016/s0140-6736(97)04318-3 · Cited by 683
Lütjohann, D., Breuer, O., Ahlborg, G., Nennesmo, I., Sidén, A., Diczfalusy, U., & Björkhem, I. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.18.9799 · Cited by 682
cDNA cloning of cholesterol 24-hydroxylase, a mediator of cholesterol homeostasis in the brain
Lund, E. G., Guileyardo, J. M., & Russell, D. W. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.13.7238 · Cited by 668
Björkhem, I., Lütjohann, D., Diczfalusy, U., Ståhle, L., Ahlborg, G., & Wahren, J. (1998) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)32188-x · Cited by 538
Rockwood, K. J., Kirkland, S., Hogan, D. B., MacKnight, C., Merry, H. R., Verreault, R., Wolfson, C. M., & McDowell, I. (2002) · Archives of Neurology · doi:10.1001/archneur.59.2.223 · Cited by 520
A New Function for the LDL Receptor: Transcytosis of LDL across the Blood–Brain Barrier
Dehouck, B., Fenart, L., Dehouck, M.-P., Pierce, A., Torpier, G., & Cecchelli, R. (1997) · The Journal of Cell Biology · doi:10.1083/jcb.138.4.877 · Cited by 490
Lipoprotein receptors in the nervous system
Herz, J., & Bock, H. H. (2002) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.71.110601.135342 · Cited by 457
Serum Lipoprotein Levels, Statin Use, and Cognitive Function in Older Women
Yaffe, K. S., Barrett-Connor, E. L., Lin, F., & Grady, D. G. (2002) · Archives of Neurology · doi:10.1001/archneur.59.3.378 · Cited by 445
Sparks, D. L., Scheff, S. W., Hunsaker, J. C., Liu, H., Landers, T., & Gross, D. R. (1994) · Experimental Neurology · doi:10.1006/exnr.1994.1044 · Cited by 443
Lund, E. G., Xie, C., Kotti, T., Turley, S. D., Dietschy, J. M., & Russell, D. W. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m303415200 · Cited by 421
Simons, M., Schwärzler, F., Lütjohann, D., von Bergmann, K., Beyreuther, K. T., DICHGANS, J., Wormstall, H., Hartmann, T., & Schulz, J. B. (2002) · Annals of Neurology · doi:10.1002/ana.10292 · Cited by 413
Neurodegeneration in the Central Nervous System of apoE-Deficient Mice
Masliah, E., Mallory, M. E., Ge, N., Alford, M. F., Veinbergs, I., & Roses, A. D. (1995) · Experimental Neurology · doi:10.1006/exnr.1995.1088 · Cited by 402
Acyl-coenzyme A: cholesterol acyltransferase modulates the generation of the amyloid β-peptide
Puglielli, L., Konopka, G., Pack-Chung, E., Ingano, L. A. M., Berezovska, O., Hyman, B. T., Chang, T. Y., Tanzi, R. E., & Kovacs, D. M. (2001) · Nature Cell Biology · doi:10.1038/ncb1001-905 · Cited by 392
Risk of Dementia Among White and African American Relatives of Patients With Alzheimer Disease
Green, R. C. (2002) · JAMA · doi:10.1001/jama.287.3.329 · Cited by 391
Lütjohann, D., Papassotiropoulos, A., Björkhem, I., Locatelli, S., Bagli, M., Oehring, R. D., Schlegel, U. S., Jessen, F., Rao, M. L., von Bergmann, K., et al. (2000) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)32052-6 · Cited by 378
Cholesterol Modulates α-Secretase Cleavage of Amyloid Precursor Protein
Bodovitz, S., & Klein, W. L. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.8.4436 · Cited by 359
Heverin, M., Bogdanović, N., Lütjohann, D., Bayer, T. A., Pikuleva, I. A., Brétillon, L., Diczfalusy, U., Winblad, B. G., & Björkhem, I. (2004) · Journal of Lipid Research · doi:10.1194/jlr.m300320-jlr200 · Cited by 325
Role of cholesterol in synapse formation and function
Pfrieger, F. W. (2003) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/s0005-2736(03)00024-5 · Cited by 325
The role of cholesterol in the biosynthesis of β-amyloid.
Frears, E. R., Stephens, D. J., Walters, C. E., Davies, H., & Austen, B. (1999) · Neuroreport · doi:10.1097/00001756-199906030-00014 · Cited by 323
Outsourcing in the brain: Do neurons depend on cholesterol delivery by astrocytes?
Pfrieger, F. W. (2003) · BioEssays · doi:10.1002/bies.10195 · Cited by 308
Cholesterol for synthesis of myelin is made locally, not imported into brain
Jurevics, H., & Morell, P. (1995) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1995.64020895.x · Cited by 302
Liver X receptors in the central nervous system: From lipid homeostasis to neuronal degeneration
Wang, L., Schuster, G. U., Hultenby, K. R., Zhang, Q., Andersson, S., & Gustafsson, J.-Α. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.172510899 · Cited by 298
Importance of a Novel Oxidative Mechanism for Elimination of Brain Cholesterol
Björkhem, I., Lütjohann, D., Breuer, O., Sakinis, A., & Wennmalm, Å. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.48.30178 · Cited by 281
Cholesterol and Alzheimer’s disease
Simons, M., Keller, P., DICHGANS, J., & Schulz, J. B. (2001) · Neurology · doi:10.1212/wnl.57.6.1089 · Cited by 257
Modulation of Secreted β-Amyloid Precursor Protein and Amyloid β-Peptide in Brain by Cholesterol
Howland, D., Trusko, S. P., Savage, M. J., Reaume, A. G., Lang, D. M., Hirsch, J. D., Maeda, N., Siman, R., Greenberg, B., Scott, R. W., et al. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.26.16576 · Cited by 256
Dehouck, B., Dehouck, M. P., Fruchart, J. C., & Cecchelli, R. (1994) · The Journal of cell biology · doi:10.1083/jcb.126.2.465 · Cited by 240
Edwards (2002) · doi:10.1016/s1537-1891(02)00175-1 · Cited by 233
Teboul, M., Enmark, E., Li, Q., Wikström, A. C., Pelto‐Huikko, M., & Gustafsson, J.-Α. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.6.2096 · Cited by 233
THE BIOLOGICAL CONVERSION OF CHOLESTEROL TO CHOLIC ACID
Bloch, K., Berg, B. N., & Rittenberg, D. (1943) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)72197-2 · Cited by 231
Do oxysterols control cholesterol homeostasis?
Björkhem, I. (2002) · Journal of Clinical Investigation · doi:10.1172/jci16388 · Cited by 224
Gong, J.-S., Kobayashi, M., Hayashi, H., Zou, K., Sawamura, N., Fujita, S. C., Yanagisawa, K., & Michikawa, M. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m203934200 · Cited by 214
Sun, Y., Wu, S., Bu, G., Onifade, M. K., Patel, S. N., LaDu, M. J., Fagan, A. M., & Holtzman, D. M. (1998) · The Journal of Neuroscience · doi:10.1523/jneurosci.18-09-03261.1998 · Cited by 213
Bogdanović, N., Brétillon, L., Lund, E. G., Diczfalusy, U., Lannfelt, L., Winblad, B. G., Russell, D. W., & Björkhem, I. (2001) · Neuroscience Letters · doi:10.1016/s0304-3940(01)02277-7 · Cited by 213
Regulation of Cholesterol Homeostasis by the Liver X Receptors in the Central Nervous System
Whitney, K. D., Watson, M. A., Collins, J. L., Benson, W. G., Stone, T. M., Numerick, M. J., Tippin, T. K., Wilson, J. G., Winegar, D. A., & Kliewer, S. A. (2002) · Molecular Endocrinology · doi:10.1210/mend.16.6.0835 · Cited by 211
Do oxysterols control cholesterol homeostasis?
Björkhem, I. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0216388 · Cited by 207
BODY CHOLESTEROL METABOLISM IN MAN. I. THE EQUILIBRATION OF SERUM AND TISSUE CHOLESTEROL*†
Chobanian, A. V., & Hollander, W. (1962) · Journal of Clinical Investigation · doi:10.1172/jci104631 · Cited by 203
Hajjar, I. M., Schumpert, J., Hirth, V., Wieland, D. M., & Eleazer, G. P. (2002) · The Journals of Gerontology Series A · doi:10.1093/gerona/57.7.m414 · Cited by 188
Bu, G., Maksymovitch, E. A., Nerbonne, J. M., & Schwartz, A. L. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)32340-2 · Cited by 185
Cholesterol and other membrane active sterols: from membrane evolution to “rafts”
Barenholz, Y. (2002) · Progress in Lipid Research · doi:10.1016/s0163-7827(01)00016-9 · Cited by 184
Generation of Viable Cholesterol-Free Mice
Wechsler, A. S., Brafman, A., Shafir, M., Heverin, M., Gottlieb, H., Damari, G. M., Gozlan-Kelner, S., Spivak, I., Moshkin, O., Fridman, E., et al. (2003) · Science · doi:10.1126/science.1090776 · Cited by 179
Meaney, S., Bodin, K., Diczfalusy, U., & Björkhem, I. (2002) · Journal of Lipid Research · doi:10.1194/jlr.m200293-jlr200 · Cited by 173
Self-citationReduction in Levels of 24S-Hydroxycholesterol by Statin Treatment in Patients With Alzheimer Disease
Vega, G. L., Weiner, M., Lipton, A. M., von Bergmann, K., Lütjohann, D., Moore, C. B., & Svetlik, D. A. (2003) · Archives of Neurology · doi:10.1001/archneur.60.4.510 · Cited by 172
Osono, Y., Woollett, L. A., Herz, J., & Dietschy, J. M. (1995) · Journal of Clinical Investigation · doi:10.1172/jci117760 · Cited by 169
Panzenboeck, U., Balazs, Z., Sovic, A., Hrzenjak, A., Levak-Frank, S., Wintersperger, A., Malle, E., & Sattler, W. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m207601200 · Cited by 169
Xie, C., Lund, E. G., Turley, S. D., Russell, D. W., & Dietschy, J. M. (2003) · Journal of Lipid Research · doi:10.1194/jlr.m300164-jlr200 · Cited by 159
Profile of cholesterol-related sterols in aged amyloid precursor protein transgenic mouse brain
Lütjohann, D., Brzezinka, A., Barth, E., Abramowski, D., Staufenbiel, M., von Bergmann, K., Beyreuther, K., Multhaup, G., & Bayer, T. A. (2002) · Journal of Lipid Research · doi:10.1194/jlr.m200071-jlr200 · Cited by 158
Plasma levels of 24S-hydroxycholesterol in patients with neurological diseases
Brétillon, L., Sidén, Å., Wahlund, L., Lütjohann, D., Minthon, L., Crisby, M., Hillert, J. A., Groth, C., Diczfalusy, U., & Björkhem, I. (2000) · Neuroscience Letters · doi:10.1016/s0304-3940(00)01466-x · Cited by 153
Locatelli, S., Lütjohann, D., Schmidt, H., Otto, C., Beisiegel†, U., & von Bergmann, K. (2002) · Archives of Neurology · doi:10.1001/archneur.59.2.213 · Cited by 152
Apolipoprotein E Genetic Variation and Alzheimer’s Disease
Rubinsztein, D. C., & Easton, D. F. (1999) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000017120 · Cited by 151
Brétillon, L., Lütjohann, D., Ståhle, L., Widhe, T. L., Bindl, L., Eggertsen, G., Diczfalusy, U., & Björkhem, I. (2000) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)32393-2 · Cited by 148
Papassotiropoulos, A., Lütjohann, D., Bagli, M., Locatelli, S., Jessen, F., Rao, M. L., Maier, W., Björkhem, I., von Bergmann, K., & Heun, R. (2000) · Neuroreport · doi:10.1097/00001756-200006260-00030 · Cited by 145
Transport of side-chain oxidized oxysterols in the human circulation
Babiker, A., & Diczfalusy, U. (1998) · Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism · doi:10.1016/s0005-2760(98)00047-2 · Cited by 129
Amyloid β peptide alters intracellular vesicle trafficking and cholesterol homeostasis
Liu, Y., Peterson, D. A., & Schubert, D. A. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.22.13266 · Cited by 128
Leoni, V., Masterman, T., Diczfalusy, U., Luca, G. D., Hillert, J. A., & Björkhem, I. (2002) · Neuroscience Letters · doi:10.1016/s0304-3940(02)00887-x · Cited by 126
Interactions of Cholesterol with Lipid Bilayers: The Preferred Configuration and Fluctuations
Kessel, A., Ben‐Tal, N., & May, S. (2001) · Biophysical Journal · doi:10.1016/s0006-3495(01)75729-3 · Cited by 125
Lovastatin enhances Aβ production and senile plaque deposition in female Tg2576 mice
Park, I.-H., Hwang, E. M., Hong, H., Boo, J. H., Oh, S. S., Lee, J., Jung, M. W., Bang, O. Y., Kim, S. U., & Mook‐Jung, I. (2002) · Neurobiology of Aging · doi:10.1016/s0197-4580(02)00155-0 · Cited by 124
Cholesterol in Alzheimer's Disease and Tauopathy
Burns, M. P., & Duff, K. (2002) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2002.tb04839.x · Cited by 121
Fassbender, K. C., Stroick, M., Bertsch, T., Ragoschke, A., Kuehl, S., Walter, S., Walter, J., Brechtel-Curth, K., Muehlhauser, F., von Bergmann, K., et al. (2002) · Neurology · doi:10.1212/wnl.59.8.1257 · Cited by 119
Lange, Y., Ye, J., & Strebel, F. (1995) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)39867-9 · Cited by 112
Xie, C.-L., Burns, D., Turley, S., & Dietschy, J. (2000) · Journal of Neuropathology and Experimental Neurology · doi:10.1093/jnen/59.12.1106 · Cited by 111
Sjögren, M. J. C., Gustafsson, K., Syversen, S., Olsson, A., Edman, Å., Davidsson, P., Wallin, A., & Blennow, K. (2003) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000069989 · Cited by 107
Galbete, J. L., Martin, T. R., PERESSINI, E., Modena, P., Bianchi, R., & Forloni, G. (2000) · Biochemical Journal · doi:10.1042/bj3480307 · Cited by 98
Smith‐Lemli‐Opitz Syndrome and the DHCR7 Gene
Jira, P. E., Waterham, H. R., Wanders, R. J. A., Smeitink, J. A. M., Sengers, R. C. A., & Wevers, R. A. (2003) · Annals of Human Genetics · doi:10.1046/j.1469-1809.2003.00034.x · Cited by 92
Rodríguez, E., Dodge, H. H., Birzescu, M., Stoehr, G. P., & Ganguli, M. (2002) · Journal of the American Geriatrics Society · doi:10.1046/j.1532-5415.2002.50515.x · Cited by 90
Meaney, S., Hassan, M., Sakinis, A., Lütjohann, D., von Bergmann, K., Wennmalm, Å., Diczfalusy, U., & Björkhem, I. (2001) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)32337-3 · Cited by 90
Self-citationBrain Lipoprotein Metabolism and Its Relation to Neurodegenerative Disease
Danik, M., Champagne, D. L., Petit-Turcotte, C., Beffert, U., & Poirier, J. (1999) · Critical Reviews in Neurobiology · doi:10.1615/critrevneurobiol.v13.i4.20 · Cited by 89
Waelsch, H., Sperry, W. M., & Stoyanoff, V. A. (1940) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)73186-4 · Cited by 84
Buxbaum, J. D. (2002) · Frontiers in bioscience · doi:10.2741/a739 · Cited by 82
Swanson, L. W., Simmons, D. M., Hofmann, S. L., Goldstein, J. L., & Brown, M. S. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.24.9821 · Cited by 81
Jackson Snipes, G., & Suter, U. (1997) · Subcellular Biochemistry · doi:10.1007/978-1-4615-5901-6_7 · Cited by 77
Zhou, C. J., Zhao, L., Inagaki, N., Guan, J., Nakajo, S., Hirabayashi, T., Kikuyama, S., & Shioda, S. (2001) · Journal of Neuroscience · doi:10.1523/jneurosci.21-03-00849.2001 · Cited by 76
Raffaı̈, R. L., & Weisgraber, K. H. (2003) · Journal of Lipid Research · doi:10.1194/jlr.r300007-jlr200 · Cited by 76
Haley, R. W. (2000) · Archives of Neurology · doi:10.1001/archneur.57.10.1410 · Cited by 75
Shanmugaratnam, J., Berg, E., Kimerer, L., Johnson, R. J., Amaratunga, A., Schreiber, B. M., & Fine, R. E. (1997) · Molecular Brain Research · doi:10.1016/s0169-328x(97)00176-9 · Cited by 68
The Role of Lipid‐Lowering Drugs in Cognitive Function: A Meta‐Analysis of Observational Studies
Etminan, M., Gill, S. S., & Samii, A. (2003) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.23.6.726.32184 · Cited by 65
Brain Cholesterol, Statins and Alzheimer’s Disease
Kirsch, C., Eckert, G. P., Koudinov, A. R., & Müller, W. E. G. (2003) · Pharmacopsychiatry · doi:10.1055/s-2003-43058 · Cited by 63
Studies on the synthesis of cholesterol in the brain of the human fetus
Plotz, E. J., Kabara, J. J., Davis, M. E., et al. (1968) · American Journal of Obstetrics and Gynecology · doi:10.1016/0002-9378(68)90565-6 · Cited by 62
Treiber-Held, S., Distl, R., Meske, V., et al. (2003) · The Journal of Pathology · doi:10.1002/path.1345 · Cited by 61
mRNA for low density lipoprotein receptor in brain and spinal cord of immature and mature rabbits.
Hofmann, S. L., Russell, D. W., Goldstein, J. L., & Brown, M. S. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.17.6312 · Cited by 60
Saito, M., Benson, E. P., Saito, M., & Rosenberg, A. (1987) · Journal of Neuroscience Research · doi:10.1002/jnr.490180208 · Cited by 58
ABCA2: a candidate regulator of neural transmembrane lipid transport
Schmitz, G., & Kaminski, W. E. (2002) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-002-8508-5 · Cited by 57
Meaney, S., Lütjohann, D., Diczfalusy, U., & Björkhem, I. (2000) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/s1388-1981(00)00070-6 · Cited by 56
Self-citationHas Nature Designed the Cholesterol Side Chain for Optimal Interaction with Phospholipids?
Bittman, R. (1997) · Sub-cellular biochemistry/Subcellular biochemistry · doi:10.1007/978-1-4615-5901-6_6 · Cited by 51
Apoptosis in the pattern formation of the ventricular wall during mouse heart organogenesis
Abdelwahid, E., Pelliniemi, L. J., Niinikoski, H., Simell, O., Tuominen, J., Rahkonen, O. P., & Jokinen, E. (1999) · The Anatomical Record · doi:10.1002/(sici)1097-0185(19991001)256:2 · Cited by 48
Temporal and spatial profiles of ABCA2‐expressing oligodendrocytes in the developing rat brain
Tanaka, Y., Yamada, K., Zhou, C. J., Ban, N., Shioda, S., & Inagaki, N. (2002) · The Journal of Comparative Neurology · doi:10.1002/cne.10493 · Cited by 47
Ishii, K., Tokuda, T., Matsushima, T., Miya, F., Shoji, S., Ikeda, S., & Tamaoka, A. (2003) · Neuroscience Letters · doi:10.1016/s0304-3940(03)00895-4 · Cited by 43
Localization and ontogeny of the orphan receptor OR-1 in the rat brain
Kainu, T., Kononen, J., Enmark, E., Gustafsson, J.-Å., & Pelto‐Huikko, M. (1996) · Journal of Molecular Neuroscience · doi:10.1007/bf02736846 · Cited by 42
Goldman, S. A., Williams, S., Barami, K., Lemmon, V., & Nedergaard, M. (1996) · Molecular and Cellular Neuroscience · doi:10.1006/mcne.1996.0003 · Cited by 40
Low density lipoprotein-receptors in primary cultures of rat glial cells
Jung‐Testas, I., Weintraub, H., Dupuis, D., Eychenne, B., Baulieu, É.-É., & Röbel, P. (1992) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/0960-0760(92)90450-w · Cited by 35
Apolipoprotein E and Alzheimer's disease: signal transduction mechanisms
Strittmatter, W. J. (2001) · Biochemical Society Symposia · doi:10.1042/bss0670101 · Cited by 30
Koper, J. W., Zeinstra, E. C., Lopes‐Cardozo, M., et al. (1984) · Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism · doi:10.1016/0005-2760(84)90233-9 · Cited by 29
Tint, G. S., BATTA, A. K., Xu, G., Shefer, S., Honda, A., Irons, M., Elias, E. R., & Salen, G. (1997) · Sub-cellular biochemistry/Subcellular biochemistry · doi:10.1007/978-1-4615-5901-6_5 · Cited by 27
Volpe, J. J., & Obert, K. A. (1981) · Archives of Biochemistry and Biophysics · doi:10.1016/0003-9861(81)90346-5 · Cited by 18
Birkenmeier, G., Grosche, J., & Reichenbach, A. (1996) · Neuroreport · doi:10.1097/00001756-199612200-00030 · Cited by 13
Studies on oxysterols : Origins, properties and roles
Meaney, S. (2003) · Figshare · Cited by 4
Self-citation
Flagged first, then by citations
Research works printed but not linked: 6
- 1834, Annales de Chimie et de Physique, 56, 160
- Norton W. Isolation and characterisation of myelin. In: Bittman R ed. Cholesterol. New York: Plenum Press; 1998.
- 1996, J Mol Neurosci, 7, 29
- 2003, Pharmacopsychiatry, 36, 113
- 2002, Neurobiol Aging, 23, 273
- 2002, Front Biosci, 7, a50
Cited by
Sorted by citations
The glymphatic system: a beginner's guide
Jessen, N. A., Munk, A. S. F., Lundgaard, I., & Nedergaard, M. (2015) · Neurochemical Research · doi:10.1007/s11064-015-1581-6 · Cited by 2,075
Recent Advancements in Pathogenesis, Diagnostics and Treatment of Alzheimer’s Disease
Khan, S., Barve, K. H., & Kumar, M. S. (2020) · Current Neuropharmacology · doi:10.2174/1570159x18666200528142429 · Cited by 820
“Out of all the brain lipids, the most abundant are cholesterol, ceramides, glucosyl ceramides, phosphatidylcholine, sphingomyelin, and sulfatides [61, 62].”
BackgroundHigh cholesterol level is essential for myelin membrane growth
Saher, G., Brügger, B., Lappe-Siefke, C., Möbius, W., Tozawa, R.-I., Wehr, M. C., Wieland, F., Ishibashi, S., & Nave, K.-A. (2005) · Nature Neuroscience · doi:10.1038/nn1426 · Cited by 799
Alzheimer's disease as homeostatic responses to age-related myelin breakdown
Bartzokis, G. (2011) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2009.08.007 · Cited by 546
Myelin Fat Facts: An Overview of Lipids and Fatty Acid Metabolism
Poitelon, Y., Kopec, A. M., & Belin, S. (2020) · Cells · doi:10.3390/cells9040812 · Cited by 394
Cholesterol in brain disease: Sometimes determinant and frequently implicated
Martín, M. G., Pfrieger, F., & Dotti, C. G. (2014) · The EMBO Reports · doi:10.15252/embr.201439225 · Cited by 304
Oligodendroglial myelination requires astrocyte-derived lipids
Camargo, N., Goudriaan, A., van Deijk, A.-L. F., Otte, W. M., Brouwers, J. F., Lodder, H., Gutmann, D. H., Nave, K.-A., Dijkhuizen, R. M., Mansvelder, H. D., et al. (2017) · PLOS Biology · doi:10.1371/journal.pbio.1002605 · Cited by 296
McKinney, J. S., & Kostis, W. J. (2012) · Stroke · doi:10.1161/strokeaha.112.655894 · Cited by 294
Associations Between Serum Cholesterol Levels and Cerebral Amyloidosis
Reed, B., Villeneuve, S., Mack, W., DeCarli, C., Chui, H. C., & Jagust, W. (2014) · JAMA Neurology · doi:10.1001/jamaneurol.2013.5390 · Cited by 267
HDL and cholesterol handling in the brain
Vitali, C., Wellington, C. L., & Calabresi, L. (2014) · Cardiovascular Research · doi:10.1093/cvr/cvu148 · Cited by 254
Riddell, D. R., Zhou, H., Comery, T. A., Kouranova, E., Lo, C. F., Warwick, H. K., Ring, R. H., Kirksey, Y., Aschmies, S., Xu, J., et al. (2007) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2007.01.011 · Cited by 244
Cholesterol and Alzheimer’s Disease; From Risk Genes to Pathological Effects
Feringa, F. M., & van der Kant, R. (2021) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2021.690372 · Cited by 226
Targeting proprotein convertase subtilisin/kexin type 9 (PCSK9): From bench to bedside
Bao, X., Liang, Y., Chang, H., Cai, T., Feng, B., Gordon, K., Zhu, Y., Shi, H., He, Y., & Xie, L. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01690-3 · Cited by 187
Bile acid signaling in neurodegenerative and neurological disorders
Grant, S. M., & DeMorrow, S. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21175982 · Cited by 185
Varma, V. R., Büşra Lüleci, H., Oommen, A. M., Varma, S., Blackshear, C. T., Griswold, M. E., An, Y., Roberts, J. A., O’Brien, R., Pletnikova, O., et al. (2021) · npj Aging and Mechanisms of Disease · doi:10.1038/s41514-021-00064-9 · Cited by 153
Cholesterol: A Novel Regulatory Role in Myelin Formation
Saher, G., Quintes, S., & Nave, K.-A. (2011) · The Neuroscientist · doi:10.1177/1073858410373835 · Cited by 144
Chakrabarti, S., Kumar Khemka, V., Banerjee, A., Chatterjee, G., Ganguly, A., & Biswas, A. (2015) · Aging and disease · doi:10.14336/ad.2014.002 · Cited by 134
Tashima, T. (2020) · Chemical and Pharmaceutical Bulletin · doi:10.1248/cpb.c19-00854 · Cited by 120
The role of lipid biomarkers in major depression
Parekh, A., Smeeth, D., Milner, Y., & Thuret, S. (2017) · Healthcare · doi:10.3390/healthcare5010005 · Cited by 120
Identification of disease markers in human cerebrospinal fluid using lipidomic and proteomic methods
Fonteh, A. N., Harrington, R. J., Huhmer, A. F., Biringer, R. G., Riggins, J. N., & Harrington, M. G. (2006) · Disease Markers · doi:10.1155/2006/202938 · Cited by 113
Schoenfeld, R., Wong, A., Silva, J., Li, M., Itoh, A., Horiuchi, M., Itoh, T., Pleasure, D., & Cortopassi, G. (2010) · Mitochondrion · doi:10.1016/j.mito.2009.12.141 · Cited by 112
Cholesterol synthesis rate in human hippocampus declines with aging
Thelen, K. M., Falkai, P., Bayer, T. A., & Lütjohann, D. (2006) · Neuroscience Letters · doi:10.1016/j.neulet.2006.04.034 · Cited by 107
Lipid metabolism in Alzheimer’s disease
Liu, Q., & Zhang, J. (2014) · Neuroscience Bulletin · doi:10.1007/s12264-013-1410-3 · Cited by 101
Development, behavior, and biomarker characterization of Smith-Lemli-Opitz syndrome: an update
Thurm, A., Tierney, E., Farmer, C., Albert, P., Joseph, L., Swedo, S., Bianconi, S., Bukelis, I., Wheeler, C., Sarphare, G., et al. (2016) · Journal of Neurodevelopmental Disorders · doi:10.1186/s11689-016-9145-x · Cited by 73
The generation and function of soluble apoE receptors in the CNS
Rebeck, G. W., LaDu, M. J., Estus, S., Bu, G., & Weeber, E. J. (2006) · Molecular Neurodegeneration · doi:10.1186/1750-1326-1-15 · Cited by 66
Segatto, M., Leboffe, L., Trapani, L., & Pallottini, V. (2014) · Current Medicinal Chemistry · doi:10.2174/0929867321666140303142902 · Cited by 65
Petek, B., Häbel, H., Xu, H., Villa-Lopez, M., Kalar, I., Hoang, M. T., Maioli, S., Pereira, J. B., Mostafaei, S., Winblad, B., et al. (2023) · Alzheimer's Research & Therapy · doi:10.1186/s13195-023-01360-0 · Cited by 65
Impaired cholesterol metabolism, neurons, and neuropsychiatric disorders
Cheon, S. Y. (2023) · Experimental Neurobiology · doi:10.5607/en23010 · Cited by 67
Lin, J.-P., Mironova, Y. A., Shrager, P., & Giger, R. J. (2017) · eLife · doi:10.7554/elife.30498 · Cited by 64
A New Hypothesis for Alzheimer’s Disease: The Lipid Invasion Model
Rudge, J. D. (2022) · Journal of Alzheimer's Disease Reports · doi:10.3233/adr-210299 · Cited by 58
Podleśny-Drabiniok, A., Novikova, G., Liu, Y., Dunst, J., Temizer, R., Giannarelli, C., Marro, S., Kreslavsky, T., Marcora, E., & Goate, A. M. (2024) · Nature Communications · doi:10.1038/s41467-024-46315-7 · Cited by 52
SREBP2 gene therapy targeting striatal astrocytes ameliorates Huntington’s disease phenotypes
Birolini, G., Verlengia, G., Talpo, F., Maniezzi, C., Zentilin, L., Giacca, M., Conforti, P., Cordiglieri, C., Caccia, C., Leoni, V., et al. (2021) · Brain · doi:10.1093/brain/awab186 · Cited by 48
Wang, S.-H., Huang, Y., Yuan, Y., Xia, W.-Q., Wang, P., & Huang, R. (2014) · Lipids in Health and Disease · doi:10.1186/1476-511x-13-175 · Cited by 44
Selective expression of LDLR and VLDLR in myelinating oligodendrocytes
Zhao, S., Hu, X., Park, J., Zhu, Y., Zhu, Q., Li, H., Luo, C., Han, R., Cooper, N., & Qiu, M. (2007) · Developmental Dynamics · doi:10.1002/dvdy.21283 · Cited by 39
Age-related influence of the HDL receptor SR-BI on synaptic plasticity and cognition
Chang, E. H., Rigotti, A., & Huerta, P. T. (2009) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2007.07.006 · Cited by 35
Statins: Neurobiological underpinnings and mechanisms in mood disorders
Walker, A. J., Kim, Y., Borissiouk, I., Rehder, R., Dodd, S., Morris, G., Nierenberg, A. A., Maes, M., Fernandes, B. S., Dean, O. M., et al. (2021) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2021.07.012 · Cited by 33
PCSK9 and the nervous system: a no-brainer?
Jaafar, A. K., Techer, R., Chemello, K., Lambert, G., & Bourane, S. (2023) · Journal of Lipid Research · doi:10.1016/j.jlr.2023.100426 · Cited by 35
“The adult brain vastly relies on endogenous synthesis for its cholesterol needs since the BBB is virtually impermeable to circulating lipoproteins (52) and since, unlike oxysterols, cholesterol molecules do not cross the BBB (53).”
BackgroundLipid metabolism transcriptomics of murine microglia in Alzheimer’s disease and neuroinflammation
Shippy, D. C., & Ulland, T. K. (2023) · Scientific Reports · doi:10.1038/s41598-023-41897-6 · Cited by 35
Biological consequences of statins in Candida species and possible implications for human health
Wikhe, K., Westermeyer, C., & Macreadie, I. G. (2007) · Biochemical Society Transactions · doi:10.1042/bst0351529 · Cited by 31
Cotto, B., Natarajaseenivasan, K., Ferrero, K., Wesley, L., Sayre, M., & Langford, D. (2018) · Glia · doi:10.1002/glia.23291 · Cited by 30
Changes in the Cerebrospinal Fluid and Plasma Lipidome in Patients with Rett Syndrome
Zandl-Lang, M., Züllig, T., Trötzmüller, M., Naegelin, Y., Abela, L., Wilken, B., Scholl-Buergi, S., Karall, D., Kappos, L., Köfeler, H., et al. (2022) · Metabolites · doi:10.3390/metabo12040291 · Cited by 30
Opposing Roles of apolipoprotein E in aging and neurodegeneration
Hudry, E., Klickstein, J., Cannavo, C., Jackson, R., Muzikansky, A., Gandhi, S., Urick, D., Sargent, T., Wrobleski, L., Roe, A. D., et al. (2019) · Life Science Alliance · doi:10.26508/lsa.201900325 · Cited by 30
Lopez, A. M., Chuang, J.-C., Posey, K. S., & Turley, S. D. (2017) · Brain Research · doi:10.1016/j.brainres.2016.10.021 · Cited by 24
Cholesterol Metabolism in CNS Diseases: The Potential of SREBP2 and LXR as Therapeutic Targets
Wang, N.-Q., Sun, P.-X., Shen, Q.-Q., & Deng, M.-Y. (2025) · Molecular Neurobiology · doi:10.1007/s12035-024-04672-w · Cited by 19
Freel, B. A., Kelvington, B. A., Sengupta, S., Mukherjee, M., & Francis, K. R. (2022) · Disease Models & Mechanisms · doi:10.1242/dmm.049843 · Cited by 17
“Disruption of cholesterol homeostasis has also been shown to perturb cell-autonomous and non-cell-autonomous functions, including inhibition of crucial signaling pathways and cellular crosstalk (Bjorkhem and Meaney, 2004; Martin et al., 2014).”
Modulation of PICALM Levels Perturbs Cellular Cholesterol Homeostasis
Mercer, J. L., Argus, J. P., Crabtree, D. M., Keenan, M. M., Wilks, M. Q., Chi, J.-T. A., Bensinger, S. J., Lavau, C. P., & Wechsler, D. S. (2015) · PLOS ONE · doi:10.1371/journal.pone.0129776 · Cited by 17
Plasma oxysterols in drug-free patients with schizophrenia
Guidara, W., Messedi, M., Naifar, M., Maalej, M., Khrouf, W., Grayaa, S., Maalej, M., Bonnefont-Rousselot, D., Lamari, F., & Ayadi, F. (2022) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2022.106123 · Cited by 11
Borrell-Pages, M., Luquero, A., Vilahur, G., Padró, T., & Badimon, L. (2024) · Cardiovascular Research · doi:10.1093/cvr/cvad159 · Cited by 10
Modulation of Brain Cholesterol Metabolism through CYP46A1 Overexpression for Rett Syndrome
Audouard, E., Khefif, N., Gillet-Legrand, B., Nobilleau, F., Bouazizi, O., Stanga, S., Despres, G., Alves, S., Lamazière, A., Cartier, N., et al. (2024) · Pharmaceutics · doi:10.3390/pharmaceutics16060756 · Cited by 7
Metadata
- Authors
- Björkhem, I., & Meaney, S.
- Affiliations
- From the Division of Clinical Chemistry, Karolinska Institute, Huddinge University Hospital, Stockholm, Sweden.
- Karolinska Institutet (SE)
- ORCID
- Meaney, Steve
- Venue
- Arteriosclerosis, Thrombosis, and Vascular Biology
- Published
- 2004-05
- Volume
- 24
- Issue
- 5
- Pages
- 806-815
- ISSN
- 1079-5642 (ISSN-L)
- 1524-4636
- OpenAlex
- W2117842413
- Cited by
- 1,044
- References
- 112
- Citations by year
- 2026: 50 · 2025: 51 · 2024: 56 · 2023: 77 · 2022: 63 · 2021: 62 · 2020: 66 · 2019: 56 · 2018: 39 · 2017: 43 · 2016: 45 · 2015: 51 · 2014: 41 · 2013: 38 · 2012: 44
- FWCI
- 7.53
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Arteriosclerosis Thrombosis and Vascular Biology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Cholesterol and Lipid Metabolism
- Life Sciences › Neuroscience › Neurology › Barrier Structure and Function Studies
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Keywords
- brain cholesterol, cholesterol homeostasis, blood-brain barrier, myelin, de novo cholesterol synthesis, 24S-hydroxycholesterol, oxysterols, cytochrome P450, cholesterol turnover, neurodegenerative diseases, Alzheimer's disease, cholesterol biosynthesis inhibitors
- MeSH terms
- Animals, Blood-Brain Barrier, Brain, Cholesterol, Homeostasis, Humans, Hydroxycholesterols, Membrane Lipids, Myelin Sheath, Nerve Degeneration, Receptors, Cytoplasmic and Nuclear, Neuroprotective Agents, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review